These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tech.Sight. Antibody design by man and nature. Wentworth P Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422 [TBL] [Abstract][Full Text] [Related]
7. Generation of three selenium-containing catalytic antibodies with high catalytic efficiency using a novel hapten design method. Su D; Ren X; You D; Li D; Mu Y; Yan G; Zhang Y; Luo Y; Xue Y; Shen J; Liu Z; Luo G Arch Biochem Biophys; 2001 Nov; 395(2):177-84. PubMed ID: 11697854 [TBL] [Abstract][Full Text] [Related]
8. Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1. Böttger V; Peters L; Micheel B J Mol Recognit; 1999; 12(3):191-7. PubMed ID: 10398409 [TBL] [Abstract][Full Text] [Related]
9. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group. Motté P; Alberici G; Ait-Abdellah M; Bellet D J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187 [TBL] [Abstract][Full Text] [Related]
12. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman JR; Berkman CE; Underiner GE J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397 [TBL] [Abstract][Full Text] [Related]
13. A selenium-containing catalytic antibody with Type I deiodinase activity. Lian G; Ding L; Chen M; Liu L; Zhao D; Ni J Biochem Biophys Res Commun; 2001 May; 283(5):1007-12. PubMed ID: 11355872 [TBL] [Abstract][Full Text] [Related]
15. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
16. Screening strategies for catalytic antitransition-state analog antibodies. Tramontano A Methods Mol Biol; 1995; 51():237-50. PubMed ID: 7581701 [No Abstract] [Full Text] [Related]
17. The interplay between binding energy and catalysis in the evolution of a catalytic antibody. Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839 [TBL] [Abstract][Full Text] [Related]